{"transactions":[{"id":726394,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":35383,"kind":"person","name":"VINK PATRICK V.J.J.","position":1,"cik":"0001557501","reported_name":"VINK PATRICK V.J.J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-25T23:12:10.000Z","date":"2026-06-23","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option will vest and become exercisable in full on June 23, 2027 subject to the Reporting Person's continued service as a director through the vesting date."}],"balance_after":20000,"derivative":{"exercise_price":2.15,"expiration_date":"2036-06-23","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001193125-26-283226","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000119312526283226/ownership.xml","form_type":"4"}},{"id":726393,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":35383,"kind":"person","name":"VINK PATRICK V.J.J.","position":1,"cik":"0001557501","reported_name":"VINK PATRICK V.J.J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-25T23:12:10.000Z","date":"2026-06-23","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest on June 23, 2027, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":85000,"source":{"system":"sec-edgar","filing":"0001193125-26-283226","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000119312526283226/ownership.xml","form_type":"4"}},{"id":1109817,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":35383,"kind":"person","name":"VINK PATRICK V.J.J.","position":1,"cik":"0001557501","reported_name":"VINK PATRICK V.J.J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-17T00:28:41.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest on June 12, 2026, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":75000,"source":{"system":"sec-edgar","filing":"0000950170-25-087015","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000095017025087015/ownership.xml","form_type":"4"}},{"id":1497881,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":35383,"kind":"person","name":"VINK PATRICK V.J.J.","position":1,"cik":"0001557501","reported_name":"VINK PATRICK V.J.J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-30T20:25:29.000Z","date":"2024-05-29","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest on May 29, 2025, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":55000,"source":{"system":"sec-edgar","filing":"0000950170-24-066622","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000095017024066622/ownership.xml","form_type":"4"}},{"id":1762599,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":35383,"kind":"person","name":"VINK PATRICK V.J.J.","position":1,"cik":"0001557501","reported_name":"VINK PATRICK V.J.J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-10T21:28:36.000Z","date":"2023-10-05","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest on October 5, 2024, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":35000,"source":{"system":"sec-edgar","filing":"0000950170-23-052701","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000095017023052701/ownership.xml","form_type":"4"}},{"id":1853907,"issuer":{"id":112267,"kind":"organization","name":"SQZ Biotechnologies Co","symbol":"SQZ"},"owners":[{"id":35383,"kind":"person","name":"VINK PATRICK V.J.J.","position":1,"cik":"0001557501","reported_name":"VINK PATRICK V.J.J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2023-06-15T20:48:26.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":39875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and become exercisable on the earlier of (i) June 14, 2024 or (ii) the day immediately prior to the date of the next annual meeting of stockholders following the date of grant, in each case subject to the recipient's continued service on the Board at such time."}],"balance_after":39875,"derivative":{"exercise_price":0.539,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":39875},"source":{"system":"sec-edgar","filing":"0001209191-23-037390","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1557501/000120919123037390/doc4.xml","form_type":"4"}},{"id":2062797,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":35383,"kind":"person","name":"VINK PATRICK V.J.J.","position":1,"cik":"0001557501","reported_name":"VINK PATRICK V.J.J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-05T21:14:35.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":15471,"price":1.29,"value":19957.59,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This stock option was issued to the Reporting Person, who elected to take stock options in lieu of $20,000 in cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in four quarterly installments on the last day of each calendar quarter during the calendar year subject to the Reporting Person's continued service as a non-employee director."}],"balance_after":15471,"derivative":{"exercise_price":1.74,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":15471},"source":{"system":"sec-edgar","filing":"0000899243-23-000983","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000089924323000983/doc4.xml","form_type":"4"}},{"id":2155768,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":35383,"kind":"person","name":"VINK PATRICK V.J.J.","position":1,"cik":"0001557501","reported_name":"VINK PATRICK V.J.J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-19T21:39:12.000Z","date":"2022-09-15","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest on September 15, 2023, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0000899243-22-031495","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000089924322031495/doc4.xml","form_type":"4"}},{"id":2229533,"issuer":{"id":112267,"kind":"organization","name":"SQZ Biotechnologies Co","symbol":"SQZ"},"owners":[{"id":35383,"kind":"person","name":"VINK PATRICK V.J.J.","position":1,"cik":"0001557501","reported_name":"VINK PATRICK V.J.J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-06-16T21:00:50.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and become exercisable on the earlier of (i) June 15, 2023 or (ii) the day immediately prior to the date of the next annual meeting of stockholders following the date of grant, in each case subject to the recipient's continued service on the Board at such time."}],"balance_after":20000,"derivative":{"exercise_price":3.23,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-22-037482","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1557501/000120919122037482/doc4.xml","form_type":"4"}},{"id":2440131,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":35383,"kind":"person","name":"VINK PATRICK V.J.J.","position":1,"cik":"0001557501","reported_name":"VINK PATRICK V.J.J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-07T22:07:46.000Z","date":"2022-01-05","kind":"grant","acquired":true,"shares":2214,"price":9.03,"value":19992.42,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This stock option was issued to the Reporting Person, who elected to take stock options in lieu of $20,000 in cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in four quarterly installments on the last day of each calendar quarter during the calendar year subject to the Reporting Person's continued service as a non-employee director."}],"balance_after":2214,"derivative":{"exercise_price":13.19,"expiration_date":"2032-01-05","underlying":"Common Stock","underlying_shares":2214},"source":{"system":"sec-edgar","filing":"0000899243-22-001376","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000089924322001376/doc4.xml","form_type":"4"}},{"id":2597974,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":35383,"kind":"person","name":"VINK PATRICK V.J.J.","position":1,"cik":"0001557501","reported_name":"VINK PATRICK V.J.J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-08-18T20:52:06.000Z","date":"2021-08-17","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option will vest and become exercisable in full on August 17, 2022 subject to the Reporting Person's continued service as a director through the vesting date."}],"balance_after":7500,"derivative":{"exercise_price":13.69,"expiration_date":"2031-08-17","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0000899243-21-033463","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000089924321033463/doc4.xml","form_type":"4"}},{"id":2647184,"issuer":{"id":112267,"kind":"organization","name":"SQZ Biotechnologies Co","symbol":"SQZ"},"owners":[{"id":35383,"kind":"person","name":"VINK PATRICK V.J.J.","position":1,"cik":"0001557501","reported_name":"VINK PATRICK V.J.J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2021-07-01T21:20:55.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and become exercisable in 36 equal monthly installments following the date of grant, subject to the Reporting Person's continued service on the Board."}],"balance_after":21000,"derivative":{"exercise_price":14.82,"expiration_date":"2031-06-30","underlying":"Common Stock","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0001209191-21-044491","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1557501/000120919121044491/doc4.xml","form_type":"4"}},{"id":2915919,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":35383,"kind":"person","name":"VINK PATRICK V.J.J.","position":1,"cik":"0001557501","reported_name":"VINK PATRICK V.J.J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-01-06T21:30:56.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":1314,"price":13.31,"value":17489.34,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This stock option was issued to the Reporting Person, who elected to take stock options in lieu of $17,500 in cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in four quarterly installments on the last day of each calendar quarter during the calendar year subject to the Reporting Person's continued service as a non-employee director."}],"balance_after":1314,"derivative":{"exercise_price":17.93,"expiration_date":"2031-01-04","underlying":"Common Stock","underlying_shares":1314},"source":{"system":"sec-edgar","filing":"0000899243-21-000695","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000089924321000695/doc4.xml","form_type":"4"}},{"id":2999336,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":35383,"kind":"person","name":"VINK PATRICK V.J.J.","position":1,"cik":"0001557501","reported_name":"VINK PATRICK V.J.J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-10-27T21:31:16.000Z","date":"2020-10-27","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option will vest and become exercisable in full on October 27, 2021 subject to the Reporting Person's continued service as a director through the vesting date."}],"balance_after":7500,"derivative":{"exercise_price":13.52,"expiration_date":"2030-10-27","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0000899243-20-029327","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000089924320029327/doc4.xml","form_type":"4"}},{"id":3318619,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":35383,"kind":"person","name":"VINK PATRICK V.J.J.","position":1,"cik":"0001557501","reported_name":"VINK PATRICK V.J.J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-01-07T00:05:59.000Z","date":"2020-01-02","kind":"grant","acquired":true,"shares":5408,"price":6.47,"value":34989.76,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This stock option was issued to the Reporting Person, who elected to take stock options in lieu of $35,000 in cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in four quarterly installments on the last day of each calendar quarter during the calendar year subject to the Reporting Person's continued service as a non-employee director."}],"balance_after":5408,"derivative":{"exercise_price":9.87,"expiration_date":"2030-01-02","underlying":"Common Stock","underlying_shares":5408},"source":{"system":"sec-edgar","filing":"0000899243-20-000628","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000089924320000628/doc4.xml","form_type":"4"}},{"id":3500743,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":35383,"kind":"person","name":"VINK PATRICK V.J.J.","position":1,"cik":"0001557501","reported_name":"VINK PATRICK V.J.J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-05T22:45:58.000Z","date":"2019-06-05","kind":"grant","acquired":true,"shares":6073,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option will vest and become exercisable in full on June 5, 2020 subject to the Reporting Person's continued service as a director through the vesting date."}],"balance_after":6073,"derivative":{"exercise_price":10.67,"expiration_date":"2029-06-05","underlying":"Common Stock","underlying_shares":6073},"source":{"system":"sec-edgar","filing":"0000899243-19-015663","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000089924319015663/doc4.xml","form_type":"4"}},{"id":3903540,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":35383,"kind":"person","name":"VINK PATRICK V.J.J.","position":1,"cik":"0001557501","reported_name":"VINK PATRICK V.J.J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-07T00:00:30.000Z","date":"2018-06-05","kind":"grant","acquired":true,"shares":6073,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option will vest and become exercisable in full on June 5, 2019, subject to the Reporting Person's continued service as a director through the vesting date."}],"balance_after":6073,"derivative":{"exercise_price":11.54,"expiration_date":"2028-06-05","underlying":"Common Stock","underlying_shares":6073},"source":{"system":"sec-edgar","filing":"0000899243-18-015325","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000089924318015325/doc4.xml","form_type":"4"}}]}